Intraperitoneal immune microenvironment and efficacy of intraperitoneal chemotherapy in patients with gastric cancer and peritoneal metastasis

Our previous study demonstrated that intraperitoneal paclitaxel improves survival outcomes in patients with gastric cancer ...